217 related articles for article (PubMed ID: 27323403)
1. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.
Liu L; Zhi Q; Shen M; Gong FR; Zhou BP; Lian L; Shen B; Chen K; Duan W; Wu MY; Tao M; Li W
Oncotarget; 2016 Jul; 7(30):47145-47162. PubMed ID: 27323403
[TBL] [Abstract][Full Text] [Related]
2. Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib.
Wang WJ; Wu MY; Shen M; Zhi Q; Liu ZY; Gong FR; Tao M; Li W
Int J Oncol; 2015 Nov; 47(5):1912-22. PubMed ID: 26398277
[TBL] [Abstract][Full Text] [Related]
3. FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R.
Su H; Jin X; Zhang X; Zhao L; Lin B; Li L; Fei Z; Shen L; Fang Y; Pan H; Xie C
J Transl Med; 2015 Mar; 13():104. PubMed ID: 25888911
[TBL] [Abstract][Full Text] [Related]
4. FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway.
Chen Y; Rao X; Huang K; Jiang X; Wang H; Teng L
J Cancer; 2017; 8(16):3142-3153. PubMed ID: 29158786
[TBL] [Abstract][Full Text] [Related]
5. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer.
Zhi X; Tao J; Xie K; Zhu Y; Li Z; Tang J; Wang W; Xu H; Zhang J; Xu Z
Cancer Lett; 2014 Apr; 346(1):104-13. PubMed ID: 24374017
[TBL] [Abstract][Full Text] [Related]
6. CDK8 regulates the angiogenesis of pancreatic cancer cells in part via the CDK8-β-catenin-KLF2 signal axis.
Wei R; Kong L; Xiao Y; Yuan H; Song Y; Wang J; Yu H; Mao S; Xu W
Exp Cell Res; 2018 Aug; 369(2):304-315. PubMed ID: 29856990
[TBL] [Abstract][Full Text] [Related]
7. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
Yu L; Li X; Li H; Chen H; Liu H
Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
[TBL] [Abstract][Full Text] [Related]
8. FH535 inhibited metastasis and growth of pancreatic cancer cells.
Wu MY; Liang RR; Chen K; Shen M; Tian YL; Li DM; Duan WM; Gui Q; Gong FR; Lian L; Li W; Tao M
Onco Targets Ther; 2015; 8():1651-70. PubMed ID: 26185454
[TBL] [Abstract][Full Text] [Related]
9. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
10. FH535 inhibits the proliferation of HepG2 cells via downregulation of the Wnt/β-catenin signaling pathway.
Liu J; Li G; Liu D; Liu J
Mol Med Rep; 2014 Apr; 9(4):1289-92. PubMed ID: 24482011
[TBL] [Abstract][Full Text] [Related]
11. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
[TBL] [Abstract][Full Text] [Related]
13. Autophagic flux modulation by Wnt/β-catenin pathway inhibition in hepatocellular carcinoma.
Turcios L; Chacon E; Garcia C; Eman P; Cornea V; Jiang J; Spear B; Liu C; Watt DS; Marti F; Gedaly R
PLoS One; 2019; 14(2):e0212538. PubMed ID: 30794613
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori promotes angiogenesis depending on Wnt/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer.
Liu N; Zhou N; Chai N; Liu X; Jiang H; Wu Q; Li Q
BMC Cancer; 2016 May; 16():321. PubMed ID: 27198692
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
16. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
[TBL] [Abstract][Full Text] [Related]
17. Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway.
Xue J; Zhu W; Song J; Jiao Y; Luo J; Yu C; Zhou J; Wu J; Chen M; Ding WQ; Cao J; Zhang S
Oncogene; 2018 Feb; 37(7):953-962. PubMed ID: 29059162
[TBL] [Abstract][Full Text] [Related]
18. Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.
Cui J; Jiang W; Wang S; Wang L; Xie K
Curr Pharm Des; 2012; 18(17):2464-71. PubMed ID: 22372504
[TBL] [Abstract][Full Text] [Related]
19. Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines.
Suknuntha K; Thita T; Togarrati PP; Ratanachamnong P; Wongtrakoongate P; Srihirun S; Slukvin I; Hongeng S
Int J Hematol; 2017 Feb; 105(2):196-205. PubMed ID: 27766528
[TBL] [Abstract][Full Text] [Related]
20. FH535 inhibits proliferation and migration of colorectal cancer cells by regulating CyclinA2 and Claudin1 gene expression.
Tu X; Hong D; Jiang Y; Lou Z; Wang K; Jiang Y; Jin L
Gene; 2019 Mar; 690():48-56. PubMed ID: 30552982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
